LivaNova PLC (LIVN)
CORE-VNS Study Further Validates Effectiveness ofLivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
CORE-VNS Study Further Validates Effectiveness ofLivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
Hoth Therapeutics Notification (HOTH)
Summit Plc - Summit Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
CNS Pharmaceuticals - New Press Release
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation
MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer
New Press Release from Annovis Bio
Teladoc - Teladoc Health to Participate in Upcoming Investor Conference
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine
ImmunoPrecise - ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery